- Home
- SOUNW vs KLTOW Comparison
SOUNW vs KLTOW Comparison
Compare SOUNW & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOUNW | KLTOW |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | 842 | 3 |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | SOUNW | KLTOW |
|---|---|---|
| Price | $2.85 | $0.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 31.3K | 10.1K |
| Earning Date | 02-27-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,297,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.05 | N/A |
| 52 Week Low | $2.27 | $0.01 |
| 52 Week High | $10.82 | $0.95 |
Technical Indicators
Market Signals| Indicator | SOUNW | KLTOW |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 59.16 |
| Support Level | $2.30 | $0.10 |
| Resistance Level | $3.50 | $0.17 |
| Average True Range (ATR) | 0.31 | 0.02 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 24.78 | 66.44 |
Price Performance
Historical ComparisonAbout SOUNW SoundHound AI Inc. Warrant
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.